Low density lipoprotein landmark trials: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) |
||
| Line 22: | Line 22: | ||
| [[ASCOT-LLA Trial]]: Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm ([[atorvastatin]]) | | [[ASCOT-LLA Trial]]: Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm ([[atorvastatin]]) | ||
|- | |- | ||
| [[PROVE IT Trial]] | | [[PROVE IT-TIMI 22 Trial]] ([[pravastatin]] or [[atorvastatin]]) | ||
|- | |- | ||
| [[ASTEROID Trial]] ([[rosuvastatin]]) | | [[ASTEROID Trial]] ([[rosuvastatin]]) | ||
Revision as of 03:30, 29 September 2014
|
Low Density Lipoprotein Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Low density lipoprotein landmark trials On the Web |
|
American Roentgen Ray Society Images of Low density lipoprotein landmark trials |
|
Risk calculators and risk factors for Low density lipoprotein landmark trials |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Landmark Trials
Statin
| WOSCOPS Trial (pravastatin) |
| AFCAPS/TexCAPS Trial (lovastatin) |
| 4S Trial (simvastatin) |
| Heart Protection Study (simvastatin) |
| ALLHAT: Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (pravastatin) |
| PROSPER Trial: Prospective Study of pravastatin in the Elderly at Risk (pravastatin) |
| ASCOT-LLA Trial: Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm (atorvastatin) |
| PROVE IT-TIMI 22 Trial (pravastatin or atorvastatin) |
| ASTEROID Trial (rosuvastatin) |
| CARDS (atorvastatin) |
| ASPEN (atorvastatin) |
| MEGA Trial (pravastatin) |
| CORONA Trial (rosuvastatin) |
| JUPITER Trial (rosuvastatin) |
| SATURN Trial (atorvastatin, rosuvastatin) |
Multiple Lipid Lowering Drugs
| HARP Study |